Cravath, Swaine & Moore LLP

Cravath, Swaine & Moore LLP‘s merger control practice continues to be a fixture on some of the most closely watched transactions in the market, regularly advising boards, corporates and financial sponsors on deals that attract sustained scrutiny from competition authorities. The team is particularly active on large-cap, multi-jurisdictional transactions, with technology, consumer products, pharmaceuticals, defence and retail featuring prominently in its workload. The practice is co-led from Washington DC by Noah Joshua Phillips, whose practice spans merger control, investigations and contentious antitrust matters across sectors including healthcare, technology and pharmaceuticals. In New York, Margaret Segall is regularly instructed on complex, heavily scrutinised transactions involving merger clearance and regulatory approval, while Andrew Finch, who joined as co-lead from Paul, Weiss, Rifkind, Wharton & Garrison LLP, brings senior DOJ experience to high-stakes antitrust litigation, investigations and merger reviews across a wide range of industries.